One of the most studied OPN single-nucleotide polymorphism is rs11730582, whose −443 CC genotype has been associated with higher expression of OPN and increased cancer risk in acute myeloid leukemia, glioma, and papillary thyroid cancer. Here, SPP1 is linked to central nervous system cancer.